TNF and tuberculosis: The low sensitivity of LTBI screening tests (tuberculin skin test (TST) and the interferon-γ-release assay (IGRA)) when performed under immunosuppressive therapies [7,9] has been posed as one of the potential factors that increase the risk of active TB during anti-TNF treatment.